UniProt ID | TPIS_HUMAN | |
---|---|---|
UniProt AC | P60174 | |
Protein Name | Triosephosphate isomerase | |
Gene Name | TPI1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 286 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MAEDGEEAEFHFAALYISGQWPRLRADTDLQRLGSSAMAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Ubiquitination | EAEFHFAALYISGQW CCEEEEEEEHHCCCC | 10.43 | 21890473 | |
14 | Acetylation | EAEFHFAALYISGQW CCEEEEEEEHHCCCC | 10.43 | 19608861 | |
14 (in isoform 1) | Acetylation | - | 10.43 | - | |
16 | Phosphorylation | EFHFAALYISGQWPR EEEEEEEHHCCCCHH | 6.57 | 25693802 | |
21 | Phosphorylation | ALYISGQWPRLRADT EEHHCCCCHHCCCCC | 5.41 | 19664995 | |
21 (in isoform 1) | Phosphorylation | - | 5.41 | 21406692 | |
28 | Phosphorylation | WPRLRADTDLQRLGS CHHCCCCCCHHHHCC | 37.31 | 20068231 | |
28 (in isoform 1) | Phosphorylation | - | 37.31 | - | |
35 | Phosphorylation | TDLQRLGSSAMAPSR CCHHHHCCCCCCCCC | 21.37 | 30622161 | |
36 | Phosphorylation | DLQRLGSSAMAPSRK CHHHHCCCCCCCCCC | 21.92 | 20860994 | |
36 (in isoform 3) | O-linked_Glycosylation | - | 21.92 | 23301498 | |
38 (in isoform 1) | Phosphorylation | - | 6.43 | 21406692 | |
41 | Phosphorylation | GSSAMAPSRKFFVGG CCCCCCCCCCEEECC | 38.27 | 20860994 | |
41 (in isoform 3) | O-linked_Glycosylation | - | 38.27 | 23301498 | |
43 | 2-Hydroxyisobutyrylation | SAMAPSRKFFVGGNW CCCCCCCCEEECCCC | 47.71 | - | |
43 | Acetylation | SAMAPSRKFFVGGNW CCCCCCCCEEECCCC | 47.71 | 23954790 | |
43 | Ubiquitination | SAMAPSRKFFVGGNW CCCCCCCCEEECCCC | 47.71 | 21890473 | |
46 (in isoform 1) | Phosphorylation | - | 12.35 | 21406692 | |
51 | Acetylation | FFVGGNWKMNGRKQS EEECCCCCCCCCCCC | 26.87 | 19608861 | |
51 | Methylation | FFVGGNWKMNGRKQS EEECCCCCCCCCCCC | 26.87 | 22632985 | |
51 | Ubiquitination | FFVGGNWKMNGRKQS EEECCCCCCCCCCCC | 26.87 | 21890473 | |
56 | 2-Hydroxyisobutyrylation | NWKMNGRKQSLGELI CCCCCCCCCCHHHHH | 45.71 | - | |
56 | Ubiquitination | NWKMNGRKQSLGELI CCCCCCCCCCHHHHH | 45.71 | - | |
58 | Phosphorylation | KMNGRKQSLGELIGT CCCCCCCCHHHHHHH | 41.18 | 29255136 | |
59 | Ubiquitination | MNGRKQSLGELIGTL CCCCCCCHHHHHHHH | 5.98 | 21890473 | |
59 (in isoform 1) | Ubiquitination | - | 5.98 | 21890473 | |
65 | Phosphorylation | SLGELIGTLNAAKVP CHHHHHHHHHHCCCC | 15.17 | 23927012 | |
68 | Nitration | ELIGTLNAAKVPADT HHHHHHHHCCCCCCC | 16.27 | - | |
69 | Ubiquitination | LIGTLNAAKVPADTE HHHHHHHCCCCCCCE | 16.59 | 21890473 | |
69 (in isoform 1) | Ubiquitination | - | 16.59 | 21890473 | |
70 | Ubiquitination | IGTLNAAKVPADTEV HHHHHHCCCCCCCEE | 46.47 | - | |
71 | Phosphorylation | GTLNAAKVPADTEVV HHHHHCCCCCCCEEE | 3.97 | 20068231 | |
71 (in isoform 1) | Phosphorylation | - | 3.97 | - | |
75 | Phosphorylation | AAKVPADTEVVCAPP HCCCCCCCEEEECCC | 32.55 | 28464451 | |
79 | Glutathionylation | PADTEVVCAPPTAYI CCCCEEEECCCCCHH | 5.93 | 22555962 | |
79 | S-palmitoylation | PADTEVVCAPPTAYI CCCCEEEECCCCCHH | 5.93 | 29575903 | |
80 | Phosphorylation | ADTEVVCAPPTAYID CCCEEEECCCCCHHH | 11.07 | 19413330 | |
80 (in isoform 1) | Phosphorylation | - | 11.07 | - | |
83 | Phosphorylation | EVVCAPPTAYIDFAR EEEECCCCCHHHHHH | 30.91 | 28796482 | |
85 | Phosphorylation | VCAPPTAYIDFARQK EECCCCCHHHHHHHH | 11.96 | 28796482 | |
96 | 2-Hydroxyisobutyrylation | ARQKLDPKIAVAAQN HHHHCCHHHHHEECC | 42.86 | - | |
96 | Acetylation | ARQKLDPKIAVAAQN HHHHCCHHHHHEECC | 42.86 | 23236377 | |
96 | Ubiquitination | ARQKLDPKIAVAAQN HHHHCCHHHHHEECC | 42.86 | 21890473 | |
104 | Glutathionylation | IAVAAQNCYKVTNGA HHHEECCEEEECCCC | 2.01 | 22555962 | |
104 | S-palmitoylation | IAVAAQNCYKVTNGA HHHEECCEEEECCCC | 2.01 | 29575903 | |
105 | Nitrated tyrosine | AVAAQNCYKVTNGAF HHEECCEEEECCCCC | 18.95 | - | |
105 | Phosphorylation | AVAAQNCYKVTNGAF HHEECCEEEECCCCC | 18.95 | 28152594 | |
106 | Acetylation | VAAQNCYKVTNGAFT HEECCEEEECCCCCC | 44.79 | 25953088 | |
106 | Methylation | VAAQNCYKVTNGAFT HEECCEEEECCCCCC | 44.79 | 70215 | |
106 | Phosphorylation | VAAQNCYKVTNGAFT HEECCEEEECCCCCC | 44.79 | - | |
106 | Ubiquitination | VAAQNCYKVTNGAFT HEECCEEEECCCCCC | 44.79 | 21890473 | |
108 | Phosphorylation | AQNCYKVTNGAFTGE ECCEEEECCCCCCCC | 24.63 | 21712546 | |
112 | Acetylation | YKVTNGAFTGEISPG EEECCCCCCCCCCCC | 10.78 | 19608861 | |
112 | Methylation | YKVTNGAFTGEISPG EEECCCCCCCCCCCC | 10.78 | 19608861 | |
112 | Ubiquitination | YKVTNGAFTGEISPG EEECCCCCCCCCCCC | 10.78 | 19608861 | |
113 | Phosphorylation | KVTNGAFTGEISPGM EECCCCCCCCCCCCC | 33.11 | 25159151 | |
117 | Phosphorylation | GAFTGEISPGMIKDC CCCCCCCCCCCEECC | 15.88 | 29255136 | |
120 | Sulfoxidation | TGEISPGMIKDCGAT CCCCCCCCEECCCCE | 3.80 | 21406390 | |
122 | Acetylation | EISPGMIKDCGATWV CCCCCCEECCCCEEE | 37.77 | 26051181 | |
122 | Ubiquitination | EISPGMIKDCGATWV CCCCCCEECCCCEEE | 37.77 | - | |
124 | Glutathionylation | SPGMIKDCGATWVVL CCCCEECCCCEEEEE | 3.20 | 22555962 | |
124 | S-palmitoylation | SPGMIKDCGATWVVL CCCCEECCCCEEEEE | 3.20 | 29575903 | |
127 | Phosphorylation | MIKDCGATWVVLGHS CEECCCCEEEEEECC | 12.22 | 28857561 | |
134 | Phosphorylation | TWVVLGHSERRHVFG EEEEEECCCCCCCCC | 30.88 | 28857561 | |
137 | Methylation | VLGHSERRHVFGESD EEECCCCCCCCCCCH | 26.69 | 115918793 | |
142 | Ubiquitination | ERRHVFGESDELIGQ CCCCCCCCCHHHHHH | 43.48 | 21890473 | |
142 (in isoform 1) | Ubiquitination | - | 43.48 | 21890473 | |
143 | Phosphorylation | RRHVFGESDELIGQK CCCCCCCCHHHHHHH | 36.44 | 19764811 | |
149 | Ubiquitination | ESDELIGQKVAHALA CCHHHHHHHHHHHHH | 30.01 | 21890473 | |
149 | Succinylation | ESDELIGQKVAHALA CCHHHHHHHHHHHHH | 30.01 | - | |
149 (in isoform 1) | Ubiquitination | - | 30.01 | 21890473 | |
156 | Ubiquitination | QKVAHALAEGLGVIA HHHHHHHHHCCCEEE | 15.03 | 21890473 | |
156 | Acetylation | QKVAHALAEGLGVIA HHHHHHHHHCCCEEE | 15.03 | 19608861 | |
156 | Succinylation | QKVAHALAEGLGVIA HHHHHHHHHCCCEEE | 15.03 | - | |
156 | Ubiquitination | QKVAHALAEGLGVIA HHHHHHHHHCCCEEE | 15.03 | 19608861 | |
156 (in isoform 1) | Ubiquitination | - | 15.03 | 21890473 | |
159 | Phosphorylation | AHALAEGLGVIACIG HHHHHHCCCEEEEEE | 3.59 | - | |
160 | Ubiquitination | HALAEGLGVIACIGE HHHHHCCCEEEEEEC | 21.46 | 21890473 | |
160 (in isoform 1) | Ubiquitination | - | 21.46 | 21890473 | |
164 | Glutathionylation | EGLGVIACIGEKLDE HCCCEEEEEECCCCH | 2.56 | 22555962 | |
164 | S-palmitoylation | EGLGVIACIGEKLDE HCCCEEEEEECCCCH | 2.56 | 29575903 | |
168 | 2-Hydroxyisobutyrylation | VIACIGEKLDEREAG EEEEEECCCCHHCCC | 56.90 | - | |
168 | Acetylation | VIACIGEKLDEREAG EEEEEECCCCHHCCC | 56.90 | 26051181 | |
168 | Ubiquitination | VIACIGEKLDEREAG EEEEEECCCCHHCCC | 56.90 | - | |
172 | Methylation | IGEKLDEREAGITEK EECCCCHHCCCCCCE | 38.44 | 115918797 | |
173 | Phosphorylation | GEKLDEREAGITEKV ECCCCHHCCCCCCEE | 49.56 | - | |
175 | Ubiquitination | KLDEREAGITEKVVF CCCHHCCCCCCEEEE | 23.69 | 21890473 | |
175 | Ubiquitination | KLDEREAGITEKVVF CCCHHCCCCCCEEEE | 23.69 | 21139048 | |
175 (in isoform 1) | Ubiquitination | - | 23.69 | 21890473 | |
177 | Phosphorylation | DEREAGITEKVVFEQ CHHCCCCCCEEEEEE | 28.92 | - | |
179 | 2-Hydroxyisobutyrylation | REAGITEKVVFEQTK HCCCCCCEEEEEEEE | 34.74 | - | |
179 | Acetylation | REAGITEKVVFEQTK HCCCCCCEEEEEEEE | 34.74 | 23954790 | |
179 | Sumoylation | REAGITEKVVFEQTK HCCCCCCEEEEEEEE | 34.74 | 25114211 | |
179 | Ubiquitination | REAGITEKVVFEQTK HCCCCCCEEEEEEEE | 34.74 | 21890473 | |
186 | 2-Hydroxyisobutyrylation | KVVFEQTKVIADNVK EEEEEEEEEEECCCC | 31.19 | - | |
186 | Acetylation | KVVFEQTKVIADNVK EEEEEEEEEEECCCC | 31.19 | 23954790 | |
186 | Succinylation | KVVFEQTKVIADNVK EEEEEEEEEEECCCC | 31.19 | - | |
186 | Succinylation | KVVFEQTKVIADNVK EEEEEEEEEEECCCC | 31.19 | 21890473 | |
186 | Ubiquitination | KVVFEQTKVIADNVK EEEEEEEEEEECCCC | 31.19 | - | |
188 | Ubiquitination | VFEQTKVIADNVKDW EEEEEEEEECCCCCH | 4.20 | 21890473 | |
188 | Acetylation | VFEQTKVIADNVKDW EEEEEEEEECCCCCH | 4.20 | 19608861 | |
188 (in isoform 1) | Acetylation | - | 4.20 | - | |
188 (in isoform 1) | Ubiquitination | - | 4.20 | 21890473 | |
193 | 2-Hydroxyisobutyrylation | KVIADNVKDWSKVVL EEEECCCCCHHHEEE | 60.79 | - | |
193 | Acetylation | KVIADNVKDWSKVVL EEEECCCCCHHHEEE | 60.79 | 23954790 | |
193 | Succinylation | KVIADNVKDWSKVVL EEEECCCCCHHHEEE | 60.79 | - | |
193 | Succinylation | KVIADNVKDWSKVVL EEEECCCCCHHHEEE | 60.79 | 23954790 | |
193 | Ubiquitination | KVIADNVKDWSKVVL EEEECCCCCHHHEEE | 60.79 | - | |
194 | Ubiquitination | VIADNVKDWSKVVLA EEECCCCCHHHEEEE | 51.07 | 21890473 | |
194 | Acetylation | VIADNVKDWSKVVLA EEECCCCCHHHEEEE | 51.07 | 19608861 | |
194 | Methylation | VIADNVKDWSKVVLA EEECCCCCHHHEEEE | 51.07 | 24129315 | |
194 | Succinylation | VIADNVKDWSKVVLA EEECCCCCHHHEEEE | 51.07 | - | |
194 (in isoform 1) | Acetylation | - | 51.07 | - | |
194 (in isoform 1) | Ubiquitination | - | 51.07 | 21890473 | |
195 | Phosphorylation | IADNVKDWSKVVLAY EECCCCCHHHEEEEE | 8.37 | 20068231 | |
195 (in isoform 1) | Phosphorylation | - | 8.37 | - | |
196 | Phosphorylation | ADNVKDWSKVVLAYE ECCCCCHHHEEEEEE | 26.21 | 28857561 | |
197 | Ubiquitination | DNVKDWSKVVLAYEP CCCCCHHHEEEEEEE | 31.91 | 21890473 | |
198 | Phosphorylation | NVKDWSKVVLAYEPV CCCCHHHEEEEEEEE | 3.39 | 20068231 | |
198 (in isoform 1) | Phosphorylation | - | 3.39 | - | |
202 | Phosphorylation | WSKVVLAYEPVWAIG HHHEEEEEEEEEEEC | 19.32 | 28796482 | |
204 | Phosphorylation | KVVLAYEPVWAIGTG HEEEEEEEEEEECCC | 17.80 | 20068231 | |
204 (in isoform 1) | Phosphorylation | - | 17.80 | - | |
209 | Nitration | YEPVWAIGTGKTATP EEEEEEECCCCCCCH | 22.22 | - | |
210 | Phosphorylation | EPVWAIGTGKTATPQ EEEEEECCCCCCCHH | 29.41 | 28152594 | |
212 | Acetylation | VWAIGTGKTATPQQA EEEECCCCCCCHHHH | 34.52 | 25953088 | |
212 | Phosphorylation | VWAIGTGKTATPQQA EEEECCCCCCCHHHH | 34.52 | 23186163 | |
212 | Ubiquitination | VWAIGTGKTATPQQA EEEECCCCCCCHHHH | 34.52 | 21890473 | |
213 | Phosphorylation | WAIGTGKTATPQQAQ EEECCCCCCCHHHHH | 36.79 | 25159151 | |
214 | Phosphorylation | AIGTGKTATPQQAQE EECCCCCCCHHHHHH | 22.29 | 24275569 | |
215 | Phosphorylation | IGTGKTATPQQAQEV ECCCCCCCHHHHHHH | 27.19 | 28985074 | |
218 | S-nitrosylation | GKTATPQQAQEVHEK CCCCCHHHHHHHHHH | 46.33 | 19483679 | |
223 | Phosphorylation | PQQAQEVHEKLRGWL HHHHHHHHHHHHHHH | 26.22 | 24275569 | |
225 | 2-Hydroxyisobutyrylation | QAQEVHEKLRGWLKS HHHHHHHHHHHHHHH | 28.71 | - | |
225 | Acetylation | QAQEVHEKLRGWLKS HHHHHHHHHHHHHHH | 28.71 | 16916647 | |
225 | Ubiquitination | QAQEVHEKLRGWLKS HHHHHHHHHHHHHHH | 28.71 | 21890473 | |
231 | Acetylation | EKLRGWLKSNVSDAV HHHHHHHHHCHHHHH | 33.21 | 19608861 | |
231 | Malonylation | EKLRGWLKSNVSDAV HHHHHHHHHCHHHHH | 33.21 | 26320211 | |
231 | Methylation | EKLRGWLKSNVSDAV HHHHHHHHHCHHHHH | 33.21 | 24129315 | |
231 | Succinylation | EKLRGWLKSNVSDAV HHHHHHHHHCHHHHH | 33.21 | - | |
231 | Ubiquitination | EKLRGWLKSNVSDAV HHHHHHHHHCHHHHH | 33.21 | - | |
232 | Phosphorylation | KLRGWLKSNVSDAVA HHHHHHHHCHHHHHH | 40.05 | 29255136 | |
235 | Phosphorylation | GWLKSNVSDAVAQST HHHHHCHHHHHHHCC | 24.89 | 29255136 | |
238 | Ubiquitination | KSNVSDAVAQSTRII HHCHHHHHHHCCEEE | 6.30 | 21890473 | |
238 | Acetylation | KSNVSDAVAQSTRII HHCHHHHHHHCCEEE | 6.30 | 19608861 | |
238 (in isoform 1) | Acetylation | - | 6.30 | - | |
238 (in isoform 1) | Ubiquitination | - | 6.30 | 21890473 | |
241 | Phosphorylation | VSDAVAQSTRIIYGG HHHHHHHCCEEEECC | 15.20 | 20068231 | |
242 | Phosphorylation | SDAVAQSTRIIYGGS HHHHHHCCEEEECCC | 17.51 | 20068231 | |
246 | Nitrated tyrosine | AQSTRIIYGGSVTGA HHCCEEEECCCCCCH | 17.05 | - | |
246 | Phosphorylation | AQSTRIIYGGSVTGA HHCCEEEECCCCCCH | 17.05 | 23927012 | |
249 | Phosphorylation | TRIIYGGSVTGATCK CEEEECCCCCCHHHH | 16.49 | 23401153 | |
251 | Phosphorylation | IIYGGSVTGATCKEL EEECCCCCCHHHHHH | 23.85 | 30266825 | |
254 | Phosphorylation | GGSVTGATCKELASQ CCCCCCHHHHHHHCC | 26.00 | 23927012 | |
255 | S-nitrosocysteine | GSVTGATCKELASQP CCCCCHHHHHHHCCC | 2.98 | - | |
255 | Glutathionylation | GSVTGATCKELASQP CCCCCHHHHHHHCCC | 2.98 | 22555962 | |
256 | Phosphoglycerylation | SVTGATCKELASQPD CCCCHHHHHHHCCCC | 51.94 | - | |
256 | Ubiquitination | SVTGATCKELASQPD CCCCHHHHHHHCCCC | 51.94 | - | |
260 | Phosphorylation | ATCKELASQPDVDGF HHHHHHHCCCCCCCE | 55.67 | 28857561 | |
273 | Phosphorylation | GFLVGGASLKPEFVD CEEECCCCCCHHHHH | 39.95 | 28857561 | |
275 | Acetylation | LVGGASLKPEFVDII EECCCCCCHHHHHHH | 39.75 | 19608861 | |
275 | Malonylation | LVGGASLKPEFVDII EECCCCCCHHHHHHH | 39.75 | 26320211 | |
275 | Ubiquitination | LVGGASLKPEFVDII EECCCCCCHHHHHHH | 39.75 | - | |
285 | Acetylation | FVDIINAKQ------ HHHHHCCCC------ | 52.64 | 70211 | |
285 | Succinylation | FVDIINAKQ------ HHHHHCCCC------ | 52.64 | 23954790 | |
285 | Ubiquitination | FVDIINAKQ------ HHHHHCCCC------ | 52.64 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TPIS_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TPIS_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TPIS_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SETB1_HUMAN | SETDB1 | physical | 16169070 | |
TPIS_HUMAN | TPI1 | physical | 8609635 | |
A4_HUMAN | APP | physical | 21832049 | |
RL40_HUMAN | UBA52 | physical | 22939629 | |
VINC_HUMAN | VCL | physical | 22939629 | |
ALDR_HUMAN | AKR1B1 | physical | 26344197 | |
AN32E_HUMAN | ANP32E | physical | 26344197 | |
ASSY_HUMAN | ASS1 | physical | 26344197 | |
CRIP1_HUMAN | CRIP1 | physical | 26344197 | |
ESTD_HUMAN | ESD | physical | 26344197 | |
HNRPR_HUMAN | HNRNPR | physical | 26344197 | |
NDUV1_HUMAN | NDUFV1 | physical | 26344197 | |
PGM2_HUMAN | PGM2 | physical | 26344197 | |
PGM2L_HUMAN | PGM2L1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615512 | Triosephosphate isomerase deficiency (TPID) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51; LYS-225; LYS-231 ANDLYS-275, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-225, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58 AND SER-117, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND MASSSPECTROMETRY. |